Literature DB >> 57788

The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.

P R Twentyman, N M Bleehen.   

Abstract

Experiments are described in which dose-response data have been obtained for EMT6 mouse tumour cells growing in vivo and exposed to various cytotoxic agents. A comparison has been made of the response of solid tumours in the flank and of rapidly growing lung nodules. The results are discussed with regard to their cell kinetic implications and compared with our results for the chemosensitivity of EMT6 cells in exponential and plateau phase growth in vitro.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57788      PMCID: PMC2024992          DOI: 10.1038/bjc.1976.46

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.

Authors:  R P Hill; J A Stanley
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

2.  Stem-cell survival and tumor control in the Lewis lung carcinoma.

Authors:  G G Steel; K Adams
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

3.  In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  M L Rosenblum; K T Wheeler; C B Wilson; M Barker; K D Knebel
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

4.  Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells.

Authors:  H Lin
Journal:  Cancer Res       Date:  1973-07       Impact factor: 12.701

5.  Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin.

Authors:  G M Hahn; L F Gordon; S D Kurkjian
Journal:  Cancer Res       Date:  1974-09       Impact factor: 12.701

6.  Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.

Authors:  G R Ray; G M Hahn; M A Bagshaw; S Kurkjian
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

7.  Response of a murine solid tumor to in vivo combined chemotherapy and irradiation.

Authors:  M D Wharam; T L Phillips; L Kane; J F Utley
Journal:  Radiology       Date:  1973-11       Impact factor: 11.105

8.  The sensitivity to bleomycin of spleen colony forming units in the mouse.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

9.  The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1974-11       Impact factor: 7.640

10.  Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

View more
  6 in total

1.  Metastasis of a transplantable mammary tumour in rats treated with cyclophosphamide and/or irradiation.

Authors:  J V Moore; B Dixon
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

2.  Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.

Authors:  Peter J Kueffer; Charles A Maitz; Aslam A Khan; Seth A Schuster; Natalia I Shlyakhtina; Satish S Jalisatgi; John D Brockman; David W Nigg; M Frederick Hawthorne
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

3.  Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.

Authors:  J A Stanley; W U Shipley; G G Steel
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

4.  A bioassay for cyclophosphamide in blood, lung and tumour.

Authors:  A C Begg; K A Smith
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

5.  Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

6.  In vivo tumour-cell proliferation after adriamycin treatment.

Authors:  R Rowley; H A Hopkins; W B Looney
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.